Nickels and Dimes

A publishing company is asking for a fee to retract an article, Ivan Oransky at Retraction Watch reports. "We've heard about a lot of barriers to retraction — author and editor stubbornness being the most frequent. But now there's a new one: A publisher that wants to charge authors $650 to retract," Oransky writes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.